Junqing Liang

417 citations
20 papers · 141 indexed · h-index 7
Topics
CAR-T cell therapy research (6 papers)Immune Cell Function and Interaction (4 papers)Dialysis and Renal Disease Management (3 papers)

In The Last Decade

Junqing Liang

19 papers receiving 139 citations

Peers

Junqing Liang
Comparison fields: 5 of 50
  • Molecular Biology 56
  • Oncology 54
  • Cancer Research 34
  • Immunology 29
  • Genetics 15
Replace Shuting Tang with:
Shuting Tang China
Yuqin Tan China
B Konopásek Czechia
Rachel Roberts‐Thomson Australia
Eriene-Heidi Sidhom United States
Yao He China
Baijun Kou United Kingdom
Wenying Zheng China
Junqing Liang relative to Shuting Tang China Shuting Tang's profile →
Citations per field
00.5×2.8×
Shuting Tang · 1×
Citations per year

Countries citing papers authored by Junqing Liang

Since Specialization
Citations

This map shows the geographic impact of Junqing Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junqing Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junqing Liang more than expected).

Fields of papers citing papers by Junqing Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junqing Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junqing Liang. The network helps show where Junqing Liang may publish in the future.

Co-authorship network of co-authors of Junqing Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Junqing Liang. A scholar is included among the top collaborators of Junqing Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junqing Liang. Junqing Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 0
3 4
4 1
5 7
6 1
7 9
8 5
9 35
10 2
11 2
12 3
13 1
14 35
15 2
16 5
17 11
18 7
19 2
20
[The effects of Tongxinluo Supermicro Powder on nuclear factor-kappaB, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression in aorta of rabbits fed with high-lipid diet].
6

About Junqing Liang

Junqing Liang is a scholar working on Nephrology, Oncology and Cancer Research, having authored 20 papers that have together received 141 indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Immune Cell Function and Interaction (4 papers) and Dialysis and Renal Disease Management (3 papers). The work is most often cited by research in Cancer Research (34 citations), Oncology (54 citations) and Immunology (29 citations). Junqing Liang has collaborated with scholars based in China, United States and Mongolia. Frequent co-authors include Hongwei Cui, Wenyan Han, Xiulan Su, Miaomiao Zhang, Zhengliang Chen, Zhigang Guo, Xiulan Su, Jiannan Chen, Kejin Zhang and Yan Zhang. Their work appears in journals such as Frontiers in Immunology, Frontiers in Psychology and Journal of Advanced Nursing.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026